SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-127526
Filing Date
2015-04-13
Accepted
2015-04-13 16:11:42
Documents
11
Period of Report
2015-04-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d910447d8k.htm 8-K 23978
2 EXHIBIT 23.1 d910447dex231.htm EX-23.1 1342
3 EXHIBIT 99.1 d910447dex991.htm EX-99.1 369042
4 EXHIBIT 99.2 d910447dex992.htm EX-99.2 307270
5 EXHIBIT 99.3 d910447dex993.htm EX-99.3 1337238
6 GRAPHIC g910447g16k59.jpg GRAPHIC 42550
7 GRAPHIC g910447g42f86.jpg GRAPHIC 40782
8 GRAPHIC g910447g71q91.jpg GRAPHIC 59482
9 GRAPHIC g910447g77h81.jpg GRAPHIC 51722
10 GRAPHIC g910447g80d15.jpg GRAPHIC 31986
11 GRAPHIC g910447g97y01.jpg GRAPHIC 82077
  Complete submission text file 0001193125-15-127526.txt   2466229
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 15766893
SIC: 2834 Pharmaceutical Preparations